Matias Trillini - Publications

FINE-ONE, more to come: moving beyond ACEis and ARBs in type 1 diabetes with kidney disease?

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: June 15, 2026

Thyroid Hormones Exhibit Promising Prognostic and Therapeutic Potential in Autosomal Dominant Polycystic Kidney Disease.

Journal: Thyroid : official journal of the American Thyroid Association

Published: June 15, 2026

Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy.

Journal: Kidney international reports

Published: April 15, 2026

Anti-nephrin antibodies are not enriched in patients with primary and posttransplant recurrent podocytopathies.

Journal: The Journal of clinical investigation

Published: January 16, 2026

Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy.

Journal: Kidney international reports

Published: October 14, 2025

Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy.

Journal: Kidney international reports

Published: September 26, 2025

Renal Clinical Study Participants Support Data Sharing and Use of Artificial Intelligence.

Journal: Kidney international reports

Published: September 11, 2025

Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: July 29, 2025

Obesity as a modifiable risk factor in patients with chronic kidney disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 18, 2025

Randomized Trial of Dapagliflozin in Patients With Nondiabetic Stage 4 CKD.

Journal: Kidney international reports

Published: February 05, 2025

How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: January 13, 2025

The future of glucagon-like peptide-1 receptor agonists in cardiovascular-kidney-metabolic diseases considerations from the ERA Diabesity Working Group.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 04, 2024